Fetal diagnosis

For Fetal Diagnosis That's Safe and Accurate, Consider Non-Invasive Prenatal Screening

Learning that you are expecting a baby is one of life's most joyous moments—but it can also come attached with some anxiety when you learn about common pregnancy risks and abnormalities. Expectant parents routinely seek out fetal diagnosis tests to rule out chromosomal disorders including Down Syndrome. As an alternative to invasive and potentially risky amniocentesis tests, EurofinsBiomnis offers NIPT (non-invasive prenatal screening) kits that offer fast and accurate results. The test draws analysis from a maternal blood sample, and can be undertaken starting at only 10 weeks of pregnancy. By choosing our non-invasive fetal screening option, risk of chromosomal defects can be screened with remarkable accuracy—over 99%.

Although most expectant parents are aware of risks for fetal genetic defects, and wonder whether Down Syndrome can be prevented, many people believe that invasive prenatal diagnosis options are the only ones available. However, effective and entirely safe non-invasive testing methods are now readily available. By opting for a Eurofins Biomnis NIPT prenatal testing, you can significantly reduce or eliminate the need for invasive and potentially risky procedures. Safe, reliable, and rapid, the test can be obtained starting in only the tenth week of pregnancy. It simultaneously detects risks for trisomies 13, 18 and 21—offering peace of mind from earlier on.

And while patients might also assume that trisomy tests are complicated types of prenatal diagnosis, is necessarily a complicated procedure, the trisomy syndrome test developed by Eurofins Biomnis is remarkably simple to prescribe and administer. It can be easily prescribed by your healthcare provider, and you can have the blood test taken at your physician's office or at a Eurofins Biomnis partner laboratory. With results of the blood test available in around 7 working days, NIPT by Eurofins Biomnis is an efficient, safe and remarkably accurate type of prenatal testing. It has been found to reduce unnecessary invasive sampling by up to 95%.